Evidence map›Paper›PMID 39817755›Full record

ArticlemSphere2025

Xiaoyun Huang, April E Johnson, Joshua N Brehm, Thi Van Thanh Do, Thomas A Auchtung, Hugh C McCullough, Armando I Lerma, Sigmund J Haidacher, Kathleen M Hoch, Thomas D Horvath and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in mSphere, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Gut microbes · 2025
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

  • Update of
    2024
5 · Who and what money

Authors and funding

13 authors.

Xiaoyun Huang *Department of Food Science and Technology and Nebraska Food for Health Center, University of Nebraska-Lincoln, Lincoln, Nebraska, USA.
April E Johnson *Department of Food Science and Technology and Nebraska Food for Health Center, University of Nebraska-Lincoln, Lincoln, Nebraska, USA.
Joshua N BrehmDepartment of Biology, Texas A&M University, College Station, Texas, USA.
Thi Van Thanh DoDepartment of Food Science and Technology and Nebraska Food for Health Center, University of Nebraska-Lincoln, Lincoln, Nebraska, USA.
Thomas A AuchtungDepartment of Food Science and Technology and Nebraska Food for Health Center, University of Nebraska-Lincoln, Lincoln, Nebraska, USA.
Hugh C McCulloughDepartment of Food Science and Technology and Nebraska Food for Health Center, University of Nebraska-Lincoln, Lincoln, Nebraska, USA.
Armando I LermaDepartment of Food Science and Technology and Nebraska Food for Health Center, University of Nebraska-Lincoln, Lincoln, Nebraska, USA.
Sigmund J HaidacherDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, Texas, USA.
Kathleen M HochDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, Texas, USA.
Thomas D HorvathDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, Texas, USA.
Joseph A SorgDepartment of Biology, Texas A&M University, College Station, Texas, USA.ORCID 0000-0001-7822-2656
Anthony M HaagDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, Texas, USA.
Jennifer M AuchtungDepartment of Food Science and Technology and Nebraska Food for Health Center, University of Nebraska-Lincoln, Lincoln, Nebraska, USA.ORCID 0000-0003-3038-583X

Funding

Targeted mass spectrometry approaches to understand CART processing and recepter interactionsP20GM113126 · NIGMS · UNIVERSITY OF NEBRASKA LINCOLN · PI POWERS, ROBERT · 2016 to 2025
$20.8M
Impact of the C. difficile small acid soluble proteins on spore physiologyR01AI172043 · NIAID · TEXAS A&M UNIVERSITY · PI SORG, JOE · 2022 to 2025
$2.5M
Protein Structure and FunctionP20GM103420 · NIGMS · UNIVERSITY OF KANSAS LAWRENCE · PI HANZLIK, ROBERT P · 2012 to 2012
$2.0M
ACQUISITION OF A QTRAP 7500 HYBRID QQQ/LIT MASS SPECTROMETER FOR PEDIATRIC TRANSLATIONAL RESEARCHS10OD036416 · OD · BAYLOR COLLEGE OF MEDICINE · PI HORVATH, THOMAS DONALD · 2024 to 2024
$598k
HHS | Centers for Disease Control and Prevention (CDC) 200-2017-96080HHS | Centers for Disease Control and Prevention (CDC) 75D301-18C-02909NIAID NIH HHS R01 AI172043NIGMS NIH HHS P20 GM103420NIGMS NIH HHS P20 GM113126NIH HHS S10 OD036416
6 · The paper itself

Abstract

Treatment with antibiotics is a major risk factor for

Indexed as

Bile Acids and SaltsClostridioides difficileProlineAnti-Bacterial AgentsClostridium InfectionsFermentationGastrointestinal MicrobiomeHumansAnti-Bacterial AgentsBile Acids and SaltsProlineantibiotic disruptionbile metabolismmicrobiotaStickland fermentation

Identifiers

PMID39817755
PMCPMC11852769

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.